🇺🇸 FDA
Patent

US 10849975

Multivalent vaccines for rabies virus and filoviruses

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 10849975 (Multivalent vaccines for rabies virus and filoviruses) held by The United States of America, as Represented by the Secretary, Department of Health and Human Services Services expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as Represented by the Secretary, Department of Health and Human Services Services
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/543